Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Debopam Samanta to Anticonvulsants

This is a "connection" page, showing publications Debopam Samanta has written about Anticonvulsants.

 
Connection Strength
  
 
 
9.047
  
  1. Samanta D, Newell G, Caraway AR, Brock E, Albert GW, Novotny EJ, Depositario Cabacar DF, Oluigbo CO, Gaillard WD, Tatachar P, Bolton JB, Wong-Kisiel L, Romanowski EF, Mcnamara NA, Eschbach K, Alexander AL, Auguste KI, Gonzalez-Giraldo E, Bernardo D, Ostendorf AP, Coryell J, Karia S, Karakas C, Javarayee PK, Pichon PD, Olaya J, Shrey DW, Reddy SB, Ganesh A, Hauptman JS, Singh RK, Ciliberto M, Marashly A, Grinspan ZM, Nangia S, Arredondo K, Miller DJ, Sattar S, Montenegro M, Agarwal N, Galan FN, Wagner J, Abel TJ, Knox AT, Perry MS. Factors Associated With More Medication Trials Before Surgical Evaluation and Postsurgical Outcomes in Pediatric Drug-Resistant Epilepsy. Neurology. 2025 Nov 11; 105(9):e214198.
    View in: PubMed
    Score: 0.884
  2. Samanta D, Naik S. Seizure-type-specific treatment responses in Lennox-Gastaut Syndrome: A comprehensive review of pharmacological, neuromodulatory, dietary, and surgical therapies. Epilepsy Behav. 2025 Sep; 170:110472.
    View in: PubMed
    Score: 0.861
  3. Samanta D, Bhalla S, Bhatia S, Fine AL, Haridas B, Karakas C, Keator CG, Koh HY, Perry MS, Stafstrom CE, Vidaurre J, Warren AEL. Antiseizure medications for Lennox-Gastaut Syndrome: Comprehensive review and proposed consensus treatment algorithm. Epilepsy Behav. 2025 Mar; 164:110261.
    View in: PubMed
    Score: 0.842
  4. Samanta D. Cognitive and behavioral impact of antiseizure medications, neuromodulation, ketogenic diet, and surgery in Lennox-Gastaut syndrome: A comprehensive review. Epilepsy Behav. 2025 Mar; 164:110272.
    View in: PubMed
    Score: 0.842
  5. Samanta D. A comprehensive review of evolving treatment strategies for Dravet syndrome: Insights from randomized trials, meta-analyses, real-world evidence, and emerging therapeutic approaches. Epilepsy Behav. 2025 Jan; 162:110171.
    View in: PubMed
    Score: 0.833
  6. Samanta D. Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm. Epilepsy Behav. 2024 Dec; 161:110123.
    View in: PubMed
    Score: 0.829
  7. Sullivan J, Gunning B, Zafar M, Guerrini R, Gecz J, Kolc KL, Zhao Y, Gasior M, Aimetti AA, Samanta D. Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy. Epilepsy Res. 2023 03; 191:107112.
    View in: PubMed
    Score: 0.737
  8. Samanta D. Changing Landscape of Dravet Syndrome Management: An Overview. Neuropediatrics. 2020 04; 51(2):135-145.
    View in: PubMed
    Score: 0.598
  9. Samanta D. Management of Alternating Hemiplegia of Childhood: A Review. Pediatr Neurol. 2020 02; 103:12-20.
    View in: PubMed
    Score: 0.586
  10. Samanta D, Willis E, Sharp GB. Absence status after starting clobazam in a patient with syndrome of continuous spike and wave during slow sleep (CSWS). Neurol India. 2014 Nov-Dec; 62(6):685-7.
    View in: PubMed
    Score: 0.414
  11. van Eeghen AM, Thiele EA, Amin S, Samanta D, Jansen AC, Stevens J, Moore-Ramdin L, de Vries PJ. Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). PLoS One. 2025; 20(6):e0324648.
    View in: PubMed
    Score: 0.216
  12. Singh A, Hadjinicolaou A, Briscoe-Abath C, Donatelli S, Salussolia C, Gupta N, Almansa AS, Zhang B, Stone S, Libenson M, Samanta D, Bolton J, Harini C. Evaluating the effectiveness of medical therapy in infantile epileptic spasms syndrome due to surgically-remediable lesions. Epilepsia. 2025 May; 66(5):1433-1446.
    View in: PubMed
    Score: 0.211
  13. Samanta D. Pharmacotherapeutic management of seizures in patients with Angleman Syndrome. Expert Opin Pharmacother. 2022 Sep; 23(13):1511-1522.
    View in: PubMed
    Score: 0.177
  14. Samanta D. Reply to comments on "A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development". Epilepsy Behav. 2022 06; 131(Pt A):108704.
    View in: PubMed
    Score: 0.174
  15. Samanta D. A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development. Epilepsy Behav. 2022 03; 128:108577.
    View in: PubMed
    Score: 0.171
  16. Samanta D. Rescue therapies for seizure emergencies: current and future landscape. Neurol Sci. 2021 Oct; 42(10):4017-4027.
    View in: PubMed
    Score: 0.165
  17. Samanta D. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review. Epilepsy Behav. 2021 01; 114(Pt A):107612.
    View in: PubMed
    Score: 0.158
  18. Samanta D. Epilepsy in Angelman syndrome: A scoping review. Brain Dev. 2021 Jan; 43(1):32-44.
    View in: PubMed
    Score: 0.155
  19. Samanta D, Garrity L, Arya R. Refractory and Super-refractory Status Epilepticus. Indian Pediatr. 2020 03 15; 57(3):239-253.
    View in: PubMed
    Score: 0.150
  20. Yuskaitis CJ, Mytinger JR, Baumer FM, Zhang B, Liu S, Samanta D, Hussain SA, Yozawitz EG, Keator CG, Joshi C, Singh RK, Bhatia S, Bhalla S, Shellhaas R, Harini C. Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms. Neurology. 2022 11 29; 99(22):e2494-e2503.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.